Cambridge Antibody, Celltech Group, Oxford GlycoSciences deal

CCH made a competitive bid for OGS that OGS called "inadequate." However, CCH offered 182p in cash for each OGS share/ADS, which values OGS at £101.4 million ($162 million) - up £18.1 million from the...